title: Lipid lowering effects on cardiovascular morbidity and mortality. Clinical evidence and therapeutic guidelines.
authors.forename: Y
authors.initials: Y
authors.lastname: Islami
authors.forename: L G
authors.initials: LG
authors.lastname: Ribeiro
mesh_terms: D002784:Cholesterol / Q000097:blood; D002792:Cholestyramine Resin / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D002994:Clofibrate / Q000627:therapeutic use; D003327:Coronary Disease / Q000097:blood / Q000517:prevention & control*; D005500:Follow-Up Studies; D015248:Gemfibrozil / Q000627:therapeutic use; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008074:Lipoproteins / Q000097:blood; D008297:Male; D011341:Probucol / Q000627:therapeutic use; D014280:Triglycerides / Q000097:blood
chemical_list: D000960:Hypolipidemic Agents; D008074:Lipoproteins; D014280:Triglycerides; D002792:Cholestyramine Resin; D002784:Cholesterol; D002994:Clofibrate; D011341:Probucol; D015248:Gemfibrozil